VCKSX Mutual Fund

VCKSX Mutual Fund

NAV$10.02
See how much of VCKSX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Mar 31, 2026

Net Assets
$15,939.74
Expense Ratio
1.95%
Dividend Yield (Current)
-
Holdings
28
Inception Date
Dec 8, 2020
Fund Family
Virtus Investment Partners
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+2.66%
1 Year-6.88%
3 Year+2.51%
5 Year-1.94%

Asset Allocation

Stocks: 99.16%
Cash: 0.83%
See how much of VCKSX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LMATLemaitre Vascular Inc5.91%
HEI.AHeico Corp. Cl. A4.92%
WSTWest Pharmaceutical Services Inc4.92%
TDYTeledyne Technologies Inc4.86%
HQYHealthequity Inc4.31%
Top 10 Concentration: 44.02%Report Date: Mar 31, 2026
Download all 28 holdings for VCKSX
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

VCKSX Mutual Fund Overview

VCKSX Mutual Fund (Virtus KAR Small-Mid Cap Growth Fund Class C) is managed by Virtus Investment Partners with $15,939.74 in net assets. VCKSX expense ratio is 1.95%, holding 28 positions across sectors including Industrials, Information Technology, Health Care. Inception date: 2020-12-08.

VCKSX performance shows a YTD return of 2.66%. The 1-year return is -6.88% and the 5-year return is -1.94%.

VCKSX top holdings include Lemaitre Vascular Inc (5.9%), Heico Corp. Cl. A (4.9%), West Pharmaceutical Services Inc (4.9%), Teledyne Technologies Inc (4.9%), Healthequity Inc (4.3%). Go to all VCKSX holdings, VCKSX sectors, or VCKSX dividends.

VCKSX can be compared against other funds. Use VCKSX overlap to find shared positions, or VCKSX vs another fund for a side-by-side view. VCKSX alternatives are available via the screener, along with tax-loss harvesting opportunities.